Introduction: The metabolic syndrome is characterized by an aggregate of metabolic disorders whose coexistence in the same individual can correspond on the one hand to a common pathophysiological mechanism and on the other hand to expose the subject to an increased risk of cardiovascular diseases. The prevalence of the metabolic syndrome is increasing rapidly in both developed and developing countries, but has been poorly described in sub-Saharan Africa. Most of them reported the components of the metabolic syndrome only in isolation. Methods: This cross-sectional study carried out on a cohort of 76 patients followed at the Sait-louis regional hospital used the definition criteria of the International Diabetes Federation. Results: The average age of our patients is 56.92 with extremes ranging from 32 to 80 years old. The sex ratio is 0.49. The average duration of diabetes progression is 68 months. The prevalence of the metabolic syndrome in this population is 67.1%. Abdominal obesity and high blood pressure are the most commonly found criteria. Abdominal obesity was the most associated component of MS in both sexes followed by high blood pressure. We found relatively weak data for dyslipidemia, especially hypertriglyceridemia. HypoHD is dyslipidemia more found in our cohort: in 45% of women and 21% of men. Conclusion: The management of the metabolic syndrome therefore requires fighting against all the factors that compose it, the first of which is the accumulation of visceral fat. Lifestyle modification is the first priority for these patients facing a society where the reduction of physical activity and the enrichment of the fat diet are becoming more and more important.
References
[1]
Ford, E.S., Giles, W. and Dietz, W. (2002) Prevalence of the Metabolic Syndrome among U.S. Adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA, 287, 356-359. https://doi.org/10.1001/jama.287.3.356
[2]
Ford, E.S. (2005) Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation among Adults in the U.S. Diabetes Care, 28, 2745-2749. https://doi.org/10.2337/diacare.28.11.2745
[3]
Gami, A.S., Witt, B.J., Howard, D.E., et al. (2007) Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death: A Systematic Review and Meta-Analysis of Longitudinal Studies. Journal of the American College of Cardiology, 49, 403-414. https://doi.org/10.1016/j.jacc.2006.09.032
[4]
Ducluzeau, P.H. (2006) Le Metabolic syndrom in 2006 Medecine du Sommeil Année 3 Octobre Novembre Décembre. https://doi.org/10.1016/S1769-4493(06)70081-4
[5]
Cornier, M.A., Dabelea, D., Hernandez, T.L., Lindstrom, R.C., Steig, A.J., Stob, N.R., et al. (2008) The Metabolic Syndrome. Endocrine Reviews, 29, 777-822. https://doi.org/10.1210/er.2008-0024
[6]
Despres, J.P. and Lemieux, I. (2006) Abdominal Obesity and Metabolic Syndrome. Nature, 444, 881-887. https://doi.org/10.1038/nature05488
[7]
Lakka, H.M., Laaksonen, D.E., Lakka, T.A., Niskanen, L.K., Kumpusalo, E., Tuomilehto, J., et al. (2002) The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-Aged Men. JAMA, 288, 2709-2716. https://doi.org/10.1001/jama.288.21.2709
[8]
Kim, J.A., Montagnani, M., Koh, K.K. and Quon, M.J. (2006) Reciprocal Relationships between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms. Circulation, 113, 1888-1904. https://doi.org/10.1161/CIRCULATIONAHA.105.563213
[9]
Alberti, K.G., Zimmet, P. and Shaw, J. (2005) IDF Epidemiology Task Force Consensus Group. The Metabolic Syndrome—A New Worldwide Definition. The Lancet, 366, 1059-1062. https://doi.org/10.1016/S0140-6736(05)67402-8
[10]
Guize, L., Thomas, F., Pannier, B., Bean, K., Jego, B. and Benetos, A. (2007) All-Cause Mortality Associated with Specific Combinations of the Metabolic Syndrome According to Recent Definitions. Diabetes Care, 30, 2381-2387. https://doi.org/10.2337/dc07-0186
[11]
Ker, J., Rheeder, P. and van Tonder, R. (2007) Frequency of Metabolic Syndrome in Screened South African Corporate Executives. Cardiovascular Journal of South Africa, 18, 30-33.
[12]
Lokrou, A. (1998) Hyperlipidémia and diabete in Côte d’Ivoire: Transversal study of 132 cas. Medecine d’Afrique Noire, 45, 555-557.
[13]
Hauhouot-Attoungbre, M.L., Yayo, S.E., Ake-Edjeme, A., et al. (2008) Does métabolic syndrome exist in Côte d’Ivoire? Immunoanalyse & Biologie Spécialisée, 23, 375-378. https://doi.org/10.1016/j.immbio.2008.10.002
[14]
Diallo, A.-M., Diallo, M.-M., Baldé, N.-M., Diakité, M., Baldé, T.-A., Bah, A., Kaké, A., Camara, A., Bah, N.-M. and Lokrou, A. (2012) Prevalence et association of metabolic syndrom métabolic in a type 2 diabetic population in Guinée. Médecine des maladies Métaboliques, 6, 542-545.
[15]
Baldé, N.M., Diallo, T.S., Diallo, A.M., Kaké, A., Camara, A., Baldé, T.A., Baldé, M.C., Diallo, A.O., Barry, A.Y., Camara, M.O.N., Camara, I.V., Bah, N.M.T., Diallo, M., Youla, C., Bah, D. and Diallo, I. (2010) Metabolic Syndrom and Diabete en Guinéa. Diabetes & Metabolism, 36, A40-A109.
[16]
Monabéka, H.-G., Kimbally-Kaky, G., Gombet, T., Moussounda-Kissama, F. and Banzouzi, B. (2012) Damba Metabolic Syndrom and Prevalence of Ischemic Cardiopathies in CHU de Brazzaville, Congo. Médecine des maladies Métaboliques, 6, 75-79.
[17]
Doupa, D., et al. (1937) Lipid Profile Frequency and the Prevalence of Dyslipidaemia from Biochemical Tests at Saint Louis University Hospital in Senegal. Pan African Medical Journal, 17, 75.
[18]
Passmore, R. and Durnin, J.W.G.A. (2006) Nutrition du sportif. In: Brunet-Guedj, E., Brunet, B., Girardier, J. and Moyen, B., Eds., Médecine du sport, Masson, Paris, 325-348.
[19]
Fezeu, L.K., Assah, F.K., Balkau, B., et al. (2008) Ten-Year Changes in Central Obesity and BMI in Rural and Urban Cameroon. Obesity (Silver Spring), 16, 1144-1147. https://doi.org/10.1038/oby.2008.44
